Free Paper: Cornea: Medical

• Tuesday  10 October 2017 | Session Time: 08:00-10:30
  
  Venue: Room 3.6

• 08:00
• Prevalence of HIV in corneal ulcer patients in desert area in North West Rajasthan at a tertiary centre: a prospective study
  Presenting Author: J.Murli Manoher INDIA
• 08:06
• Severe ocular chemical injury at a London ophthalmic referral hospital: a three-year retrospective observational study
  Presenting Author: J.Hoffman UK
• 08:12
• Subconjunctival and topical plasminogen drops as definitive and safe treatment in recurrent ligneous conjunctivitis: reducing the concern of taking these patients to the surgery room
  Presenting Author: D.Ortiz-Vaquerizas SPAIN
• 08:18
• Discussion
• 08:24
• Anterior segment optical coherence tomography (ASOCT) as a differentiating tool between herpetic stromal keratitis and endothelitis
  Presenting Author: T. Agarwal INDIA
• 08:30
• Antivascular endothelial growth factor in the approach to infectious keratitis


  Presenting Author: T.Torrent SPAIN
• 08:36
• Impact of corticosteroids in fungal keratitis
  Presenting Author: K.Belkhadir MOROCCO
• 08:42
• Microbiological profile of infectious keratitis in a reference centre
  Presenting Author: M.Astete CHILE
• 08:48
• Discussion
• 08:54
• Mitomycin C (MMC) and Interferon α2B (IFNα2B) in the management of ocular surface squamous neoplasia (OSSN): when does it help?
  Presenting Author: R.Rajagopal INDIA
• 09:00
• To report the outcome of treatment of non invasive ocular surface squamous neoplasia with topical mitomycin C as primary therapy
  Presenting Author: Y.Singhal INDIA
• 09:06
• Within-session and between-session repeatability of corneal thickness in patients with endothelial disease
  Presenting Author: F.Arnalich SPAIN
• 09:12
• Comparison of corneal endothelium in uncontrolled diabetes mellitus and normal population
  Presenting Author: S.Kimyon TURKEY
• 09:18
• Discussion
• 09:24
• Prevalence and risk factors for dry eye disease in Chinese type II diabetes
  Presenting Author: A.Ma HONG KONG
• 09:30
• Comparison of a point of care diagnostic test with a laboratory-based quantitative test for detection of MMP-9 in dry eye disease
  Presenting Author: A.Garg INDIA
• 09:36
• Lifitegrast 5.0% for the treatment of dry eye disease: responder analysis for reductions in eye dryness score in two phase 3 randomized controlled trials
  Presenting Author: E. Donnenfeld USA
• 09:42
• Discussion
• 09:48
• Topical platelet rich plasma eye drops (e-PRP) in the treatment of severe ocular surface diseases
  Presenting Author: L.Espandar USA
• 09:54
• Hyperalgesia and allodynia eye pain in dry eye disease and sicca syndrome associated with presbyopia and VDT overuse
  Presenting Author: E.Mai TAIWAN
• 10:00
• Dry eye disease ranking among common reasons for seeking eye care in a United States claims database
  Presenting Author: I.Özer Stillman USA
• 10:06
• Limbal stem cell deficiency (LSCD): demographics and clinical features of a large case series
  Presenting Author: E.Sarnicola ITALY
• 10:12
• Evaluation of dry eye disease in newly diagnosed anxiety and depression patients using anterior segment optical coherence tomography
  Presenting Author: M.Ulusoy TURKEY
• 10:18
• Discussion